News & Updates
Showing Multidisciplinary articles
Showing

LNG-IUS use ups risk of depression
Use of a levonorgestrel-releasing intrauterine system (LNG-IUS) appears to increase the risk of incident depression, defined as initiation of an antidepressant or receipt of a depression diagnosis, in a dose-dependent manner, suggests a study.
LNG-IUS use ups risk of depression
11 Sep 2024
Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
The use of tenecteplase in the extended time window of 4.5–24 hours improves functional outcomes in patients with ischaemic stroke when endovascular thrombectomy (EVT) is not immediately available, findings from the phase III TRACE-III* trial suggest.
Tenecteplase at 4.5–24 hours without thrombectomy feasible for ischaemic stroke
11 Sep 2024
MyPELINDUNG campaign continues to advocate COVID-19 vaccination and early treatment
The partner organizations in MyPELINDUNG have pledged their continuous support to the cause of keeping Malaysians healthy post-COVID-19 pandemic.
MyPELINDUNG campaign continues to advocate COVID-19 vaccination and early treatment
11 Sep 2024
Hydroxychloroquine protects SLE patients against CV events
Among patients with systemic lupus erythematosus (SLE), those who use of hydroxychloroquine are less likely to experience cardiovascular events, as reported in a study.





